nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Zileuton—asthma	0.0372	0.0603	CbGbCtD
Bexarotene—CYP2C9—Zafirlukast—asthma	0.0328	0.0531	CbGbCtD
Bexarotene—CYP3A4—Fluticasone furoate—asthma	0.0321	0.0519	CbGbCtD
Bexarotene—CYP2C9—Formoterol—asthma	0.0317	0.0513	CbGbCtD
Bexarotene—CYP2C9—Arformoterol—asthma	0.0317	0.0513	CbGbCtD
Bexarotene—CYP3A4—Budesonide—asthma	0.0286	0.0463	CbGbCtD
Bexarotene—CYP3A4—Indacaterol—asthma	0.0261	0.0423	CbGbCtD
Bexarotene—CYP3A4—Ciclesonide—asthma	0.0261	0.0423	CbGbCtD
Bexarotene—CYP2C9—Theophylline—asthma	0.0253	0.041	CbGbCtD
Bexarotene—CYP3A4—Salmeterol—asthma	0.0243	0.0393	CbGbCtD
Bexarotene—CYP3A4—Flunisolide—asthma	0.0243	0.0393	CbGbCtD
Bexarotene—CYP3A4—Salbutamol—asthma	0.0243	0.0393	CbGbCtD
Bexarotene—CYP2C9—Montelukast—asthma	0.024	0.0388	CbGbCtD
Bexarotene—CYP2C9—Loratadine—asthma	0.024	0.0388	CbGbCtD
Bexarotene—CYP3A4—Ipratropium bromide—asthma	0.0217	0.0351	CbGbCtD
Bexarotene—CYP3A4—Zileuton—asthma	0.0217	0.0351	CbGbCtD
Bexarotene—CYP3A4—Fluticasone Propionate—asthma	0.0207	0.0334	CbGbCtD
Bexarotene—CYP3A4—Zafirlukast—asthma	0.0191	0.0309	CbGbCtD
Bexarotene—CYP3A4—Tiotropium—asthma	0.0164	0.0266	CbGbCtD
Bexarotene—CYP3A4—Aminophylline—asthma	0.0157	0.0253	CbGbCtD
Bexarotene—CYP3A4—Theophylline—asthma	0.0147	0.0238	CbGbCtD
Bexarotene—CYP3A4—Montelukast—asthma	0.014	0.0226	CbGbCtD
Bexarotene—CYP3A4—Loratadine—asthma	0.014	0.0226	CbGbCtD
Bexarotene—CYP3A4—Methylprednisolone—asthma	0.0128	0.0207	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—asthma	0.00967	0.0157	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—asthma	0.0083	0.0134	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—asthma	0.0083	0.0134	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—asthma	0.00819	0.0133	CbGbCtD
Bexarotene—CYP3A4—Hydrocortisone—asthma	0.00776	0.0126	CbGbCtD
Bexarotene—CYP3A4—Prednisone—asthma	0.00773	0.0125	CbGbCtD
Bexarotene—CYP3A4—Dexamethasone—asthma	0.00483	0.00781	CbGbCtD
Bexarotene—RXRA—Biological oxidations—ALDH2—asthma	0.000219	0.00309	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—SERPINE1—asthma	0.000219	0.00308	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—asthma	0.000218	0.00307	CbGpPWpGaD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	0.000214	0.00302	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—SERPINE1—asthma	0.000213	0.00301	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—CARM1—asthma	0.000213	0.003	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—asthma	0.000211	0.00298	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PRMT5—asthma	0.00021	0.00296	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GSTT1—asthma	0.000208	0.00294	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—asthma	0.000208	0.00293	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—HNMT—asthma	0.000207	0.00292	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—CARM1—asthma	0.0002	0.00282	CbGpPWpGaD
Bexarotene—CYP3A4—Estrogen metabolism—GSTM1—asthma	0.000199	0.0028	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000199	0.0028	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PRMT5—asthma	0.000197	0.00278	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—NQO1—asthma	0.000197	0.00278	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.000186	0.00263	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—POMC—asthma	0.000177	0.00249	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000172	0.00243	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PARP1—asthma	0.000169	0.00239	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—GSTP1—asthma	0.000165	0.00232	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—HMOX1—asthma	0.000162	0.00229	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—ESR2—asthma	0.00016	0.00226	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—SMAD3—asthma	0.00016	0.00225	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PARP1—asthma	0.000159	0.00224	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—asthma	0.000158	0.00223	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IL3—asthma	0.000155	0.00219	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—asthma	0.000155	0.00219	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—ALDH2—asthma	0.000155	0.00218	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000154	0.00217	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—NR3C1—asthma	0.000154	0.00217	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—GSTM1—asthma	0.000151	0.00213	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—ESR2—asthma	0.000151	0.00212	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—STAT3—asthma	0.000149	0.0021	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—AGER—asthma	0.000146	0.00206	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GSTP1—asthma	0.000144	0.00204	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	0.00014	0.00197	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—asthma	0.000138	0.00195	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—LEP—asthma	0.000137	0.00193	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC26A4—asthma	0.000136	0.00191	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PLA2G4A—asthma	0.000133	0.00188	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GSTM1—asthma	0.000133	0.00187	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—PDGFB—asthma	0.00013	0.00183	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—asthma	0.000129	0.00182	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—asthma	0.000128	0.0018	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—VDR—asthma	0.000127	0.00179	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC30A8—asthma	0.000124	0.00175	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ATP4A—asthma	0.000124	0.00175	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.000123	0.00173	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	0.000122	0.00172	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—VDR—asthma	0.00012	0.00169	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SMAD3—asthma	0.000119	0.00168	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR3C1—asthma	0.000114	0.00161	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—SMAD3—asthma	0.000112	0.00158	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALOX15—asthma	0.000108	0.00152	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	0.000108	0.00152	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR3C1—asthma	0.000108	0.00152	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—SERPINE1—asthma	0.000107	0.00151	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—CARM1—asthma	0.000104	0.00147	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—asthma	0.000104	0.00147	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CHAT—asthma	0.000103	0.00145	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PRMT5—asthma	0.000103	0.00145	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—asthma	0.000103	0.00145	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CARM1—asthma	0.000103	0.00145	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDK2—asthma	0.000102	0.00144	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000101	0.00143	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—CAT—asthma	9.93e-05	0.0014	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CARM1—asthma	9.82e-05	0.00138	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CARM1—asthma	9.64e-05	0.00136	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—asthma	9.6e-05	0.00135	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—POMC—asthma	9.38e-05	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALOX5—asthma	9.19e-05	0.0013	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LTC4S—asthma	8.84e-05	0.00125	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CARM1—asthma	8.77e-05	0.00124	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—DNMT1—asthma	8.59e-05	0.00121	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—CARM1—asthma	8.34e-05	0.00118	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PARP1—asthma	8.29e-05	0.00117	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—ALDH2—asthma	8.18e-05	0.00115	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PARP1—asthma	8.14e-05	0.00115	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—asthma	8.13e-05	0.00115	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—DNMT1—asthma	8.08e-05	0.00114	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SERPINE1—asthma	7.99e-05	0.00113	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ESR2—asthma	7.85e-05	0.00111	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTT1—asthma	7.78e-05	0.0011	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ESR2—asthma	7.71e-05	0.00109	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LTA4H—asthma	7.67e-05	0.00108	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PARP1—asthma	7.66e-05	0.00108	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—SERPINE1—asthma	7.51e-05	0.00106	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	7.5e-05	0.00106	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	7.41e-05	0.00105	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—STAT3—asthma	7.3e-05	0.00103	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ESR2—asthma	7.25e-05	0.00102	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—asthma	7.24e-05	0.00102	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	6.88e-05	0.00097	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TGFB1—asthma	6.76e-05	0.000954	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ARG1—asthma	6.7e-05	0.000945	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	6.59e-05	0.000929	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	6.43e-05	0.000906	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—asthma	6.32e-05	0.000891	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—asthma	6.23e-05	0.000878	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ADCY2—asthma	6.19e-05	0.000872	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—asthma	6.16e-05	0.000869	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—VDR—asthma	6.12e-05	0.000863	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDH7A1—asthma	6.06e-05	0.000855	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—asthma	6e-05	0.000846	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SMAD3—asthma	5.83e-05	0.000823	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ARG2—asthma	5.81e-05	0.000819	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—VDR—asthma	5.76e-05	0.000811	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SMAD3—asthma	5.73e-05	0.000808	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR3C1—asthma	5.61e-05	0.000791	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR3C1—asthma	5.51e-05	0.000777	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SMAD3—asthma	5.49e-05	0.000774	CbGpPWpGaD
Bexarotene—Alopecia—Betamethasone—asthma	5.49e-05	0.000176	CcSEcCtD
Bexarotene—Alopecia—Dexamethasone—asthma	5.49e-05	0.000176	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PPP2CA—asthma	5.48e-05	0.000773	CbGpPWpGaD
Bexarotene—Nausea—Salbutamol—asthma	5.48e-05	0.000176	CcSEcCtD
Bexarotene—Hypertension—Hydrocortisone—asthma	5.47e-05	0.000175	CcSEcCtD
Bexarotene—Discomfort—Prednisolone—asthma	5.45e-05	0.000175	CcSEcCtD
Bexarotene—Haemoglobin—Prednisone—asthma	5.44e-05	0.000175	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	5.42e-05	0.000764	CbGpPWpGaD
Bexarotene—Haemorrhage—Prednisone—asthma	5.41e-05	0.000174	CcSEcCtD
Bexarotene—Erythema—Betamethasone—asthma	5.41e-05	0.000174	CcSEcCtD
Bexarotene—Erythema—Dexamethasone—asthma	5.41e-05	0.000174	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—ALDH2—asthma	5.39e-05	0.00076	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTP1—asthma	5.39e-05	0.00076	CbGpPWpGaD
Bexarotene—Myalgia—Hydrocortisone—asthma	5.39e-05	0.000173	CcSEcCtD
Bexarotene—RXRB—Gene Expression—SMAD3—asthma	5.39e-05	0.00076	CbGpPWpGaD
Bexarotene—Malaise—Triamcinolone—asthma	5.38e-05	0.000173	CcSEcCtD
Bexarotene—Anxiety—Hydrocortisone—asthma	5.37e-05	0.000172	CcSEcCtD
Bexarotene—Malaise—Methylprednisolone—asthma	5.36e-05	0.000172	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	5.36e-05	0.000756	CbGpPWpGaD
Bexarotene—Vertigo—Triamcinolone—asthma	5.36e-05	0.000172	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.35e-05	0.000172	CcSEcCtD
Bexarotene—Syncope—Triamcinolone—asthma	5.35e-05	0.000172	CcSEcCtD
Bexarotene—Vertigo—Methylprednisolone—asthma	5.34e-05	0.000172	CcSEcCtD
Bexarotene—Syncope—Methylprednisolone—asthma	5.33e-05	0.000171	CcSEcCtD
Bexarotene—Discomfort—Hydrocortisone—asthma	5.33e-05	0.000171	CcSEcCtD
Bexarotene—Connective tissue disorder—Prednisone—asthma	5.32e-05	0.000171	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTP1—asthma	5.32e-05	0.00075	CbGpPWpGaD
Bexarotene—Nausea—Budesonide—asthma	5.31e-05	0.00017	CcSEcCtD
Bexarotene—Oedema—Prednisolone—asthma	5.29e-05	0.00017	CcSEcCtD
Bexarotene—Loss of consciousness—Triamcinolone—asthma	5.24e-05	0.000168	CcSEcCtD
Bexarotene—Loss of consciousness—Methylprednisolone—asthma	5.23e-05	0.000168	CcSEcCtD
Bexarotene—Shock—Prednisolone—asthma	5.2e-05	0.000167	CcSEcCtD
Bexarotene—Cough—Triamcinolone—asthma	5.2e-05	0.000167	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—asthma	5.2e-05	0.000733	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR3C1—asthma	5.18e-05	0.00073	CbGpPWpGaD
Bexarotene—Oedema—Hydrocortisone—asthma	5.17e-05	0.000166	CcSEcCtD
Bexarotene—Tachycardia—Prednisolone—asthma	5.16e-05	0.000166	CcSEcCtD
Bexarotene—RXRB—Gene Expression—PPP2CA—asthma	5.16e-05	0.000727	CbGpPWpGaD
Bexarotene—Hypertension—Triamcinolone—asthma	5.15e-05	0.000165	CcSEcCtD
Bexarotene—Hypertension—Methylprednisolone—asthma	5.13e-05	0.000165	CcSEcCtD
Bexarotene—Infection—Hydrocortisone—asthma	5.13e-05	0.000165	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTT1—asthma	5.13e-05	0.000723	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Prednisolone—asthma	5.11e-05	0.000164	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—asthma	5.1e-05	0.000719	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	5.09e-05	0.000718	CbGpPWpGaD
Bexarotene—Shock—Hydrocortisone—asthma	5.08e-05	0.000163	CcSEcCtD
Bexarotene—Myalgia—Triamcinolone—asthma	5.07e-05	0.000163	CcSEcCtD
Bexarotene—Nervous system disorder—Hydrocortisone—asthma	5.07e-05	0.000163	CcSEcCtD
Bexarotene—Arthralgia—Methylprednisolone—asthma	5.06e-05	0.000163	CcSEcCtD
Bexarotene—Myalgia—Methylprednisolone—asthma	5.06e-05	0.000163	CcSEcCtD
Bexarotene—Eye disorder—Prednisone—asthma	5.06e-05	0.000162	CcSEcCtD
Bexarotene—Anxiety—Methylprednisolone—asthma	5.05e-05	0.000162	CcSEcCtD
Bexarotene—Tachycardia—Hydrocortisone—asthma	5.04e-05	0.000162	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.03e-05	0.000161	CcSEcCtD
Bexarotene—RXRA—Gene Expression—CARM1—asthma	5.02e-05	0.000708	CbGpPWpGaD
Bexarotene—Skin disorder—Hydrocortisone—asthma	5.02e-05	0.000161	CcSEcCtD
Bexarotene—Ill-defined disorder—Betamethasone—asthma	5.02e-05	0.000161	CcSEcCtD
Bexarotene—Ill-defined disorder—Dexamethasone—asthma	5.02e-05	0.000161	CcSEcCtD
Bexarotene—Discomfort—Triamcinolone—asthma	5.01e-05	0.000161	CcSEcCtD
Bexarotene—Discomfort—Methylprednisolone—asthma	5e-05	0.000161	CcSEcCtD
Bexarotene—Hyperhidrosis—Hydrocortisone—asthma	4.99e-05	0.00016	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	4.97e-05	0.000701	CbGpPWpGaD
Bexarotene—Dry mouth—Triamcinolone—asthma	4.96e-05	0.000159	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—asthma	4.95e-05	0.000698	CbGpPWpGaD
Bexarotene—Anorexia—Hydrocortisone—asthma	4.92e-05	0.000158	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—asthma	4.91e-05	0.000158	CcSEcCtD
Bexarotene—Confusional state—Methylprednisolone—asthma	4.89e-05	0.000157	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—asthma	4.88e-05	0.000689	CbGpPWpGaD
Bexarotene—Malaise—Betamethasone—asthma	4.88e-05	0.000157	CcSEcCtD
Bexarotene—Malaise—Dexamethasone—asthma	4.88e-05	0.000157	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—asthma	4.88e-05	0.000687	CbGpPWpGaD
Bexarotene—Oedema—Triamcinolone—asthma	4.86e-05	0.000156	CcSEcCtD
Bexarotene—Vertigo—Dexamethasone—asthma	4.86e-05	0.000156	CcSEcCtD
Bexarotene—Vertigo—Betamethasone—asthma	4.86e-05	0.000156	CcSEcCtD
Bexarotene—Syncope—Betamethasone—asthma	4.85e-05	0.000156	CcSEcCtD
Bexarotene—Syncope—Dexamethasone—asthma	4.85e-05	0.000156	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—asthma	4.83e-05	0.000155	CcSEcCtD
Bexarotene—Infection—Triamcinolone—asthma	4.83e-05	0.000155	CcSEcCtD
Bexarotene—Infection—Methylprednisolone—asthma	4.82e-05	0.000155	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALOX5AP—asthma	4.82e-05	0.000679	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALOX15—asthma	4.82e-05	0.000679	CbGpPWpGaD
Bexarotene—Shock—Triamcinolone—asthma	4.79e-05	0.000154	CcSEcCtD
Bexarotene—Insomnia—Prednisolone—asthma	4.78e-05	0.000154	CcSEcCtD
Bexarotene—Alopecia—Prednisone—asthma	4.78e-05	0.000154	CcSEcCtD
Bexarotene—Shock—Methylprednisolone—asthma	4.78e-05	0.000153	CcSEcCtD
Bexarotene—Nervous system disorder—Methylprednisolone—asthma	4.76e-05	0.000153	CcSEcCtD
Bexarotene—Loss of consciousness—Betamethasone—asthma	4.75e-05	0.000153	CcSEcCtD
Bexarotene—Loss of consciousness—Dexamethasone—asthma	4.75e-05	0.000153	CcSEcCtD
Bexarotene—Paraesthesia—Prednisolone—asthma	4.75e-05	0.000153	CcSEcCtD
Bexarotene—Tachycardia—Triamcinolone—asthma	4.75e-05	0.000152	CcSEcCtD
Bexarotene—Tachycardia—Methylprednisolone—asthma	4.74e-05	0.000152	CcSEcCtD
Bexarotene—Skin disorder—Methylprednisolone—asthma	4.71e-05	0.000151	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—asthma	4.71e-05	0.000151	CcSEcCtD
Bexarotene—Erythema—Prednisone—asthma	4.71e-05	0.000151	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Hydrocortisone—asthma	4.71e-05	0.000151	CcSEcCtD
Bexarotene—Hyperhidrosis—Triamcinolone—asthma	4.7e-05	0.000151	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—LEP—asthma	4.69e-05	0.000662	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Methylprednisolone—asthma	4.69e-05	0.000151	CcSEcCtD
Bexarotene—Insomnia—Hydrocortisone—asthma	4.67e-05	0.00015	CcSEcCtD
Bexarotene—Hypertension—Betamethasone—asthma	4.67e-05	0.00015	CcSEcCtD
Bexarotene—Hypertension—Dexamethasone—asthma	4.67e-05	0.00015	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—asthma	4.64e-05	0.000655	CbGpPWpGaD
Bexarotene—Paraesthesia—Hydrocortisone—asthma	4.64e-05	0.000149	CcSEcCtD
Bexarotene—Myalgia—Betamethasone—asthma	4.6e-05	0.000148	CcSEcCtD
Bexarotene—Myalgia—Dexamethasone—asthma	4.6e-05	0.000148	CcSEcCtD
Bexarotene—RXRA—Metabolism—CHAT—asthma	4.59e-05	0.000648	CbGpPWpGaD
Bexarotene—Anxiety—Dexamethasone—asthma	4.59e-05	0.000147	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—asthma	4.59e-05	0.000147	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—asthma	4.55e-05	0.000146	CcSEcCtD
Bexarotene—Discomfort—Betamethasone—asthma	4.55e-05	0.000146	CcSEcCtD
Bexarotene—Dyspepsia—Hydrocortisone—asthma	4.55e-05	0.000146	CcSEcCtD
Bexarotene—Pain—Prednisolone—asthma	4.52e-05	0.000145	CcSEcCtD
Bexarotene—Decreased appetite—Hydrocortisone—asthma	4.49e-05	0.000144	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Hydrocortisone—asthma	4.46e-05	0.000143	CcSEcCtD
Bexarotene—Fatigue—Hydrocortisone—asthma	4.45e-05	0.000143	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—asthma	4.43e-05	0.000142	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—asthma	4.42e-05	0.000142	CcSEcCtD
Bexarotene—Pain—Hydrocortisone—asthma	4.42e-05	0.000142	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—asthma	4.41e-05	0.000142	CcSEcCtD
Bexarotene—Oedema—Betamethasone—asthma	4.41e-05	0.000142	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—asthma	4.4e-05	0.000141	CcSEcCtD
Bexarotene—Insomnia—Methylprednisolone—asthma	4.39e-05	0.000141	CcSEcCtD
Bexarotene—Infection—Dexamethasone—asthma	4.39e-05	0.000141	CcSEcCtD
Bexarotene—Infection—Betamethasone—asthma	4.39e-05	0.000141	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—asthma	4.37e-05	0.00014	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—asthma	4.37e-05	0.00014	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—asthma	4.36e-05	0.00014	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—asthma	4.36e-05	0.00014	CcSEcCtD
Bexarotene—Anaemia—Prednisone—asthma	4.35e-05	0.00014	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	4.35e-05	0.000613	CbGpPWpGaD
Bexarotene—Shock—Dexamethasone—asthma	4.34e-05	0.000139	CcSEcCtD
Bexarotene—Shock—Betamethasone—asthma	4.34e-05	0.000139	CcSEcCtD
Bexarotene—Dyspnoea—Triamcinolone—asthma	4.34e-05	0.000139	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—asthma	4.33e-05	0.000139	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—asthma	4.33e-05	0.000139	CcSEcCtD
Bexarotene—Agitation—Prednisone—asthma	4.33e-05	0.000139	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—asthma	4.32e-05	0.000139	CcSEcCtD
Bexarotene—Thrombocytopenia—Betamethasone—asthma	4.32e-05	0.000139	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—asthma	4.31e-05	0.000138	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—asthma	4.31e-05	0.000138	CcSEcCtD
Bexarotene—Dyspepsia—Triamcinolone—asthma	4.28e-05	0.000137	CcSEcCtD
Bexarotene—Dyspepsia—Methylprednisolone—asthma	4.27e-05	0.000137	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—asthma	4.27e-05	0.000137	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—asthma	4.27e-05	0.000137	CcSEcCtD
Bexarotene—Feeling abnormal—Hydrocortisone—asthma	4.26e-05	0.000137	CcSEcCtD
Bexarotene—Malaise—Prednisone—asthma	4.25e-05	0.000136	CcSEcCtD
Bexarotene—Vertigo—Prednisone—asthma	4.23e-05	0.000136	CcSEcCtD
Bexarotene—Gastrointestinal pain—Hydrocortisone—asthma	4.22e-05	0.000136	CcSEcCtD
Bexarotene—Syncope—Prednisone—asthma	4.22e-05	0.000136	CcSEcCtD
Bexarotene—RXRA—Gene Expression—DNMT1—asthma	4.21e-05	0.000594	CbGpPWpGaD
Bexarotene—Anorexia—Dexamethasone—asthma	4.21e-05	0.000135	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—asthma	4.21e-05	0.000135	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—asthma	4.19e-05	0.000135	CcSEcCtD
Bexarotene—Fatigue—Methylprednisolone—asthma	4.18e-05	0.000134	CcSEcCtD
Bexarotene—Pain—Triamcinolone—asthma	4.16e-05	0.000134	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—asthma	4.14e-05	0.000133	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALOX5—asthma	4.09e-05	0.000577	CbGpPWpGaD
Bexarotene—Abdominal pain—Hydrocortisone—asthma	4.08e-05	0.000131	CcSEcCtD
Bexarotene—Body temperature increased—Hydrocortisone—asthma	4.08e-05	0.000131	CcSEcCtD
Bexarotene—Hypertension—Prednisone—asthma	4.07e-05	0.000131	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	4.04e-05	0.000569	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	4.04e-05	0.000569	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—asthma	4.02e-05	0.000129	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—asthma	4.02e-05	0.000129	CcSEcCtD
Bexarotene—Myalgia—Prednisone—asthma	4.01e-05	0.000129	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—asthma	4.01e-05	0.000129	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—asthma	4.01e-05	0.000129	CcSEcCtD
Bexarotene—Feeling abnormal—Methylprednisolone—asthma	4e-05	0.000128	CcSEcCtD
Bexarotene—Anxiety—Prednisone—asthma	4e-05	0.000128	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—asthma	3.99e-05	0.000128	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—asthma	3.99e-05	0.000128	CcSEcCtD
Bexarotene—RXRA—Gene Expression—PARP1—asthma	3.99e-05	0.000563	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.98e-05	0.000128	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—asthma	3.97e-05	0.000127	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—asthma	3.96e-05	0.000127	CcSEcCtD
Bexarotene—Paraesthesia—Betamethasone—asthma	3.96e-05	0.000127	CcSEcCtD
Bexarotene—Discomfort—Prednisone—asthma	3.96e-05	0.000127	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—IL6R—asthma	3.93e-05	0.000555	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—asthma	3.91e-05	0.000552	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CARM1—asthma	3.91e-05	0.000551	CbGpPWpGaD
Bexarotene—Hypersensitivity—Prednisolone—asthma	3.9e-05	0.000125	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—asthma	3.89e-05	0.000125	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—asthma	3.89e-05	0.000125	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	3.85e-05	0.000543	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—DCN—asthma	3.85e-05	0.000543	CbGpPWpGaD
Bexarotene—Body temperature increased—Triamcinolone—asthma	3.85e-05	0.000123	CcSEcCtD
Bexarotene—RXRG—Gene Expression—SERPINE1—asthma	3.84e-05	0.000542	CbGpPWpGaD
Bexarotene—Oedema—Prednisone—asthma	3.84e-05	0.000123	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—asthma	3.84e-05	0.000123	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—asthma	3.84e-05	0.000123	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—asthma	3.84e-05	0.000123	CcSEcCtD
Bexarotene—Infection—Prednisone—asthma	3.82e-05	0.000123	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—asthma	3.81e-05	0.000122	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—asthma	3.81e-05	0.000122	CcSEcCtD
Bexarotene—Hypersensitivity—Hydrocortisone—asthma	3.81e-05	0.000122	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—asthma	3.81e-05	0.000122	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—asthma	3.81e-05	0.000122	CcSEcCtD
Bexarotene—Shock—Prednisone—asthma	3.78e-05	0.000121	CcSEcCtD
Bexarotene—RXRA—Gene Expression—ESR2—asthma	3.78e-05	0.000533	CbGpPWpGaD
Bexarotene—Pain—Betamethasone—asthma	3.77e-05	0.000121	CcSEcCtD
Bexarotene—Pain—Dexamethasone—asthma	3.77e-05	0.000121	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—asthma	3.77e-05	0.000121	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—asthma	3.75e-05	0.00012	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALDH2—asthma	3.74e-05	0.000528	CbGpPWpGaD
Bexarotene—Skin disorder—Prednisone—asthma	3.73e-05	0.00012	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—asthma	3.72e-05	0.000119	CcSEcCtD
Bexarotene—Asthenia—Hydrocortisone—asthma	3.71e-05	0.000119	CcSEcCtD
Bexarotene—Anorexia—Prednisone—asthma	3.66e-05	0.000118	CcSEcCtD
Bexarotene—Pruritus—Hydrocortisone—asthma	3.66e-05	0.000117	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—asthma	3.64e-05	0.000117	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—asthma	3.64e-05	0.000117	CcSEcCtD
Bexarotene—RXRB—Gene Expression—SERPINE1—asthma	3.61e-05	0.00051	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Betamethasone—asthma	3.61e-05	0.000116	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dexamethasone—asthma	3.61e-05	0.000116	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—asthma	3.6e-05	0.000508	CbGpPWpGaD
Bexarotene—Hypersensitivity—Triamcinolone—asthma	3.58e-05	0.000115	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—asthma	3.58e-05	0.000115	CcSEcCtD
Bexarotene—RXRA—Metabolism—GSTT1—asthma	3.56e-05	0.000502	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—asthma	3.55e-05	0.000501	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RHOA—asthma	3.55e-05	0.000501	CbGpPWpGaD
Bexarotene—Diarrhoea—Hydrocortisone—asthma	3.54e-05	0.000114	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—asthma	3.51e-05	0.000494	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Prednisone—asthma	3.5e-05	0.000112	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—POMC—asthma	3.5e-05	0.000494	CbGpPWpGaD
Bexarotene—Dizziness—Prednisolone—asthma	3.5e-05	0.000112	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—asthma	3.49e-05	0.000112	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—asthma	3.49e-05	0.000112	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—asthma	3.49e-05	0.000112	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—asthma	3.49e-05	0.000112	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—asthma	3.49e-05	0.000112	CcSEcCtD
Bexarotene—Asthenia—Methylprednisolone—asthma	3.48e-05	0.000112	CcSEcCtD
Bexarotene—Insomnia—Prednisone—asthma	3.48e-05	0.000112	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—asthma	3.45e-05	0.000111	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—asthma	3.44e-05	0.000111	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—asthma	3.43e-05	0.00011	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	3.43e-05	0.000484	CbGpPWpGaD
Bexarotene—Dizziness—Hydrocortisone—asthma	3.42e-05	0.00011	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—asthma	3.38e-05	0.000109	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—asthma	3.34e-05	0.000107	CcSEcCtD
Bexarotene—Rash—Prednisolone—asthma	3.34e-05	0.000107	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—asthma	3.33e-05	0.000107	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—asthma	3.32e-05	0.000107	CcSEcCtD
Bexarotene—Fatigue—Prednisone—asthma	3.31e-05	0.000106	CcSEcCtD
Bexarotene—Headache—Prednisolone—asthma	3.31e-05	0.000106	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—LTC4S—asthma	3.3e-05	0.000466	CbGpPWpGaD
Bexarotene—Constipation—Prednisone—asthma	3.29e-05	0.000106	CcSEcCtD
Bexarotene—Vomiting—Hydrocortisone—asthma	3.29e-05	0.000105	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—asthma	3.28e-05	0.000463	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	3.27e-05	0.000462	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—asthma	3.27e-05	0.000461	CbGpPWpGaD
Bexarotene—Rash—Hydrocortisone—asthma	3.26e-05	0.000105	CcSEcCtD
Bexarotene—Dermatitis—Hydrocortisone—asthma	3.25e-05	0.000104	CcSEcCtD
Bexarotene—Headache—Hydrocortisone—asthma	3.24e-05	0.000104	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—asthma	3.22e-05	0.000454	CbGpPWpGaD
Bexarotene—Dizziness—Triamcinolone—asthma	3.22e-05	0.000103	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—asthma	3.21e-05	0.000103	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—asthma	3.17e-05	0.000102	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—asthma	3.17e-05	0.000102	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—asthma	3.17e-05	0.000102	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—asthma	3.14e-05	0.000101	CcSEcCtD
Bexarotene—Nausea—Prednisolone—asthma	3.14e-05	0.000101	CcSEcCtD
Bexarotene—Pruritus—Betamethasone—asthma	3.12e-05	0.0001	CcSEcCtD
Bexarotene—Pruritus—Dexamethasone—asthma	3.12e-05	0.0001	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—asthma	3.12e-05	0.00044	CbGpPWpGaD
Bexarotene—Vomiting—Triamcinolone—asthma	3.09e-05	9.93e-05	CcSEcCtD
Bexarotene—Vomiting—Methylprednisolone—asthma	3.09e-05	9.91e-05	CcSEcCtD
Bexarotene—Nausea—Hydrocortisone—asthma	3.07e-05	9.85e-05	CcSEcCtD
Bexarotene—Rash—Triamcinolone—asthma	3.07e-05	9.85e-05	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—asthma	3.06e-05	9.84e-05	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—asthma	3.06e-05	9.83e-05	CcSEcCtD
Bexarotene—Dermatitis—Methylprednisolone—asthma	3.06e-05	9.82e-05	CcSEcCtD
Bexarotene—Headache—Triamcinolone—asthma	3.05e-05	9.79e-05	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—asthma	3.04e-05	9.76e-05	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—asthma	3.04e-05	9.76e-05	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—asthma	3.04e-05	9.76e-05	CcSEcCtD
Bexarotene—Diarrhoea—Dexamethasone—asthma	3.02e-05	9.7e-05	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—asthma	3.02e-05	9.7e-05	CcSEcCtD
Bexarotene—RXRA—Gene Expression—VDR—asthma	3e-05	0.000423	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NQO1—asthma	2.96e-05	0.000417	CbGpPWpGaD
Bexarotene—Dizziness—Dexamethasone—asthma	2.92e-05	9.37e-05	CcSEcCtD
Bexarotene—Dizziness—Betamethasone—asthma	2.92e-05	9.37e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—ADCY2—asthma	2.9e-05	0.000408	CbGpPWpGaD
Bexarotene—Nausea—Triamcinolone—asthma	2.89e-05	9.28e-05	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—asthma	2.88e-05	9.26e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.87e-05	0.000405	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LTA4H—asthma	2.86e-05	0.000404	CbGpPWpGaD
Bexarotene—Hypersensitivity—Prednisone—asthma	2.83e-05	9.09e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—MMP9—asthma	2.82e-05	0.000398	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SMAD3—asthma	2.81e-05	0.000396	CbGpPWpGaD
Bexarotene—Vomiting—Betamethasone—asthma	2.81e-05	9.01e-05	CcSEcCtD
Bexarotene—Vomiting—Dexamethasone—asthma	2.81e-05	9.01e-05	CcSEcCtD
Bexarotene—Rash—Betamethasone—asthma	2.78e-05	8.94e-05	CcSEcCtD
Bexarotene—Rash—Dexamethasone—asthma	2.78e-05	8.94e-05	CcSEcCtD
Bexarotene—Dermatitis—Dexamethasone—asthma	2.78e-05	8.93e-05	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—asthma	2.78e-05	8.93e-05	CcSEcCtD
Bexarotene—Headache—Dexamethasone—asthma	2.77e-05	8.88e-05	CcSEcCtD
Bexarotene—Headache—Betamethasone—asthma	2.77e-05	8.88e-05	CcSEcCtD
Bexarotene—Asthenia—Prednisone—asthma	2.76e-05	8.86e-05	CcSEcCtD
Bexarotene—Pruritus—Prednisone—asthma	2.72e-05	8.73e-05	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NR3C1—asthma	2.7e-05	0.000381	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPP2CA—asthma	2.69e-05	0.000379	CbGpPWpGaD
Bexarotene—Diarrhoea—Prednisone—asthma	2.63e-05	8.45e-05	CcSEcCtD
Bexarotene—Nausea—Betamethasone—asthma	2.62e-05	8.42e-05	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—asthma	2.62e-05	8.42e-05	CcSEcCtD
Bexarotene—Dizziness—Prednisone—asthma	2.54e-05	8.16e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—VEGFA—asthma	2.53e-05	0.000357	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—asthma	2.51e-05	0.000354	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—asthma	2.5e-05	0.000353	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ARG1—asthma	2.5e-05	0.000353	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—asthma	2.47e-05	0.000348	CbGpPWpGaD
Bexarotene—Vomiting—Prednisone—asthma	2.44e-05	7.85e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—HMOX1—asthma	2.43e-05	0.000343	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ITPR1—asthma	2.43e-05	0.000343	CbGpPWpGaD
Bexarotene—Rash—Prednisone—asthma	2.42e-05	7.78e-05	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—asthma	2.42e-05	7.78e-05	CcSEcCtD
Bexarotene—Headache—Prednisone—asthma	2.41e-05	7.73e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—CAT—asthma	2.4e-05	0.000339	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—asthma	2.33e-05	0.000328	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—asthma	2.31e-05	0.000326	CbGpPWpGaD
Bexarotene—Nausea—Prednisone—asthma	2.28e-05	7.33e-05	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—EGFR—asthma	2.28e-05	0.000321	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLA2G4A—asthma	2.27e-05	0.00032	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—asthma	2.27e-05	0.00032	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH7A1—asthma	2.26e-05	0.000319	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LTC4S—asthma	2.18e-05	0.000307	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—asthma	2.17e-05	0.000306	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ARG2—asthma	2.17e-05	0.000306	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP2CA—asthma	2.09e-05	0.000295	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.9e-05	0.000268	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LTA4H—asthma	1.89e-05	0.000266	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—asthma	1.88e-05	0.000266	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX5AP—asthma	1.8e-05	0.000253	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX15—asthma	1.8e-05	0.000253	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—asthma	1.75e-05	0.000247	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CHAT—asthma	1.72e-05	0.000242	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ARG1—asthma	1.65e-05	0.000233	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—asthma	1.6e-05	0.000226	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX5—asthma	1.53e-05	0.000216	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH7A1—asthma	1.49e-05	0.00021	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—asthma	1.46e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CARM1—asthma	1.46e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DCN—asthma	1.44e-05	0.000203	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ARG2—asthma	1.43e-05	0.000202	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—asthma	1.4e-05	0.000197	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH2—asthma	1.4e-05	0.000197	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.34e-05	0.00019	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—asthma	1.33e-05	0.000187	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—asthma	1.28e-05	0.00018	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	1.23e-05	0.000173	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX15—asthma	1.19e-05	0.000167	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX5AP—asthma	1.19e-05	0.000167	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CHAT—asthma	1.13e-05	0.000159	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—asthma	1.12e-05	0.000157	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NQO1—asthma	1.11e-05	0.000156	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADCY2—asthma	1.08e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.07e-05	0.000151	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX5—asthma	1.01e-05	0.000142	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CARM1—asthma	9.62e-06	0.000136	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DCN—asthma	9.48e-06	0.000134	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	9.35e-06	0.000132	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH2—asthma	9.22e-06	0.00013	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—asthma	9.22e-06	0.00013	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—asthma	9.09e-06	0.000128	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ITPR1—asthma	9.07e-06	0.000128	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAT—asthma	8.97e-06	0.000126	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—asthma	8.77e-06	0.000124	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G4A—asthma	8.47e-06	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—asthma	8.47e-06	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP2CA—asthma	7.8e-06	0.00011	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NQO1—asthma	7.29e-06	0.000103	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADCY2—asthma	7.13e-06	0.000101	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—asthma	6.08e-06	8.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—asthma	6e-06	8.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—asthma	5.99e-06	8.44e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ITPR1—asthma	5.98e-06	8.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAT—asthma	5.92e-06	8.34e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G4A—asthma	5.59e-06	7.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—asthma	5.59e-06	7.88e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—asthma	5.46e-06	7.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—asthma	5.22e-06	7.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP2CA—asthma	5.14e-06	7.25e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—asthma	4.78e-06	6.73e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—asthma	4.16e-06	5.87e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—asthma	3.95e-06	5.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—asthma	3.6e-06	5.08e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—asthma	3.44e-06	4.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—asthma	3.15e-06	4.44e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—asthma	2.75e-06	3.87e-05	CbGpPWpGaD
